The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The folate receptor as a rational therapeutic target for personalized cancer treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2014) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2013-0953-sa · Cited by 1,762
Combining immunotherapy and targeted therapies in cancer treatment
Vanneman, M., & Dranoff, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3237 · Cited by 1,586
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Self-citationDistribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Qiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., & Goldman, I. D. (2006) · Cell · doi:10.1016/j.cell.2006.09.041 · Cited by 847
Overexpression of folate binding protein in ovarian cancers
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f · Cited by 521
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kalli, K. R., Oberg, A. L., Keeney, G. L., Christianson, T. J. H., Low, P. S., Knutson, K. L., & Hartmann, L. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.11.020 · Cited by 475
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 437
Self-citationBanerjee, S., & Kaye, S. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2243 · Cited by 357
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Garin‐Chesa, P., Campbell, I., Saigo, P. E., Lewis, J. L., Old, L. J., & Rettig, W. J. (1993) · PubMed Central · Cited by 299
Tumor detection using folate receptor-targeted imaging agents
Sega, E. I., & Low, P. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9155-6 · Cited by 291
Folate receptor overexpression is associated with poor outcome in breast cancer
Hartmann, L. C., Keeney, G. L., Lingle, W. L., Christianson, T. J. H., Varghese, B., Hillman, D., Oberg, A. L., & Low, P. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22811 · Cited by 245
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
Gonzalez de Castro, D., Clarke, P. A., Al-Lazikani, B., & Workman, P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.237 · Cited by 239
Naumann, R. W., Coleman, R. L., Burger, R. A., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N. Y., DePasquale, S. E., Nowara, E., Gilbert, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7685 · Cited by 238
Self-citationInhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.
Drebin, J. A., Link, V. C., Weinberg, R. A., & Greene, M. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9129 · Cited by 233
Wibowo, A. S., Singh, M., Reeder, K. M., Carter, J. J., Kovach, A. R., Meng, W., Ratnam, M., Zhang, F., & Dann, C. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308827110 · Cited by 211
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical
Leamon, C. P., Parker, M. A., Vlahov, I. R., Xu, L.-C., Reddy, J. A., Vetzel, M., & Douglas, N. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0200430 · Cited by 210
Self-citationRationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205
Self-citationPreclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Self-citationToffoli, G., Russo, A. G., Gallo, A., Cernigoi, C., Miotti, S., Sorio, R., & Boiocchi, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<121::aid-ijc4>3.0.co;2-v · Cited by 164
Nunez, M. I., Behrens, C., Woods, D. M., Lin, H., Suraokar, M., Kadara, H., Hofstetter, W., Kalhor, N., Lee, J. J., Franklin, W., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824de09c · Cited by 160
Konner, J. A., Bell-McGuinn, K. M., Sabbatini, P., Hensley, M. L., Tew, W. P., Pandit-Taskar, N., Els, N. V., Phillips, M. D., Schweizer, C., Weil, S. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0700 · Cited by 159
Zhao, R., Min, S. H., Qiu, A., Sakaris, A., Goldberg, G. L., Sandoval, C., Malatack, J. J., Rosenblatt, D. S., & Goldman, I. D. (2007) · Blood · doi:10.1182/blood-2007-02-077099 · Cited by 156
The α folate receptor is highly activated in malignant pleural mesothelioma
Bueno, R., Appasani, K., Mercer, H., et al. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111176 · Cited by 155
Armstrong, D. K., White, A. J., Weil, S. C., Phillips, M. D., & Coleman, R. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.002 · Cited by 153
Chen, Y., Chang, M., Huang, C., Chiang, Y., Lin, H.-W., Chen, C., Hsieh, C., & Cheng, W. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.11.010 · Cited by 145
Fisher, R. E., Siegel, B. A., Edell, S. L., Oyesiku, N. M., Morgenstern, D. E., Messmann, R. A., & Amato, R. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049478 · Cited by 143
Personalizing Oncology: Perspectives and Prospects
Mendelsohn, J. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3605 · Cited by 137
Morris, R. T., Joyrich, R. N., Naumann, R. W., Shah, N. P., Maurer, A. H., Strausś, H. W., Uszler, J. M., Symanowski, J. T., Ellis, P. R., & Harb, W. A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu024 · Cited by 115
Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy, J. A., Xu, L.-C., Parker, N. L., Vetzel, M., & Leamon, C. P. (2004) · PubMed · Cited by 113
Self-citationFranklin, W. A., Waintrub, M., Edwards, D. P., Christensen, K., Prendegrast, P., Woods, J. E., Bunn, P. A., & Kolhouse, S. F. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570719 · Cited by 112
Siu, M. K. Y., Kong, D. S. H., Chan, H. Y., Wong, E. S. Y., Ip, P. P. C., Jiang, L., Ngan, H., Le, X., & Cheung, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047201 · Cited by 108
Shia, J., Klimstra, D. S., Nitzkorski, J. R., Low, P. S., Gonen, M., Landmann, R., Weiser, M. R., Franklin, W. A., Prendergast, F. G., Murphy, L., et al. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.013 · Cited by 106
Matherly, L. H., Wilson, M. R., & Hou, Z. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055723 · Cited by 95
VEGF Signaling in Cancer Treatment
Sia, D., Alsinet, C., Newell, P., & Villanueva, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990590 · Cited by 90
Clinical translation of folate receptor-targeted therapeutics
Teng, L., Xie, J., Teng, L., & Lee, R. J. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.694863 · Cited by 89
The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
Crane, L. M. A., Arts, H. J. G., van Oosten, M., Low, P. S., van der Zee, A. G. J., van Dam, G. M., & Bart, J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0052-6 · Cited by 88
Christoph, D. C., Asuncion, B. R., Hassan, B., Tran, C., Maltzman, J. D., O'Shannessy, D. J., Wynes, M. W., Gauler, T. C., Wohlschlaeger, J., Hoiczyk, M., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827628ff · Cited by 85
Lasry, I., Berman, B., Straussberg, R., Sofer, Y., Bessler, H., Sharkia, M., Glaser, F., Jansen, G., Drori, S., & Assaraf, Y. G. (2008) · Blood · doi:10.1182/blood-2008-04-150276 · Cited by 78
Self-citationDespierre, E., Lambrechts, S., Leunen, K., Berteloot, P., Neven, P., Amant, F., O'Shannessy, D. J., Somers, E. B., & Vergote, I. B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.024 · Cited by 75
Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Müller, C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315777 · Cited by 70
Chapter 4 Molecular Mechanisms of Adaptation to Folate Deficiency
Ifergan, I., & Assaraf, Y. G. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00404-4 · Cited by 63
Self-citationFolate and folate receptor alpha antagonists mechanism of action in ovarian cancer
Walters, C. L., Arend, R. C., Armstrong, D. K., Naumann, R. W., & Alvarez, R. D. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.07.080 · Cited by 61
Dosio, F., Milla, P., & Cattel, L. (2010) · PubMed · Cited by 54
O'Shannessy, D. J., Somers, E. B., Palmer, L. M., Thiel, R. P., Oberoi, P., Heath, R., & Marcucci, L. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-29 · Cited by 52
The proton-coupled folate transporter: physiological and pharmacological roles
Zhao, R., & Goldman, I. D. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.011 · Cited by 45
Li, P. Y., Vecchio, S. D., Fonti, R., Carriero, M. V., Potena, M. I., Botti, G., Miotti, S., Lastoria, S., Ménard, S., COLNAGHI, M. I., et al. (1996) · PubMed · Cited by 44
Jager, N. A., Teteloshvili, N., Zeebregts, C. J., Westra, J., & Bijl, M. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.002 · Cited by 41
EC145: a novel targeted agent for adenocarcinoma of the lung
Pribble, P., & Edelman, M. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.671294 · Cited by 40
Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
Edelman, M. J., Harb, W. A., Pal, S. E., Boccia, R. V., Kraut, M., Bonomi, P., Conley, B. A., Rogers, J., Messmann, R. A., & Garon, E. B. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318267d051 · Cited by 36
Hurdles in anticancer drug development from a regulatory perspective
Jönsson, B., & Bergh, J. C. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.14 · Cited by 33
Longa, S. D., & Arcovito, A. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.05.012 · Cited by 30
Thomas, A., Maltzman, J. D., & Hassan, R. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.021 · Cited by 26
Targeted therapies of solid cancers: new options, new challenges
Awada, A. H., & Aftimos, P. G. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835ff318 · Cited by 23
Kurkjian, C. D., LoRusso, P. M., Sankhala, K. K., Birrer, M. J., Kirby, M. W., Ladd, S., Hawes, S. J., Running, K. L., O’Leary, J. J., & Moore, K. N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2573 · Cited by 18
Ab, O., Bartle, L. M., Rui, L., et al. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-4576 · Cited by 7
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Antibody-Drug Conjugate-Based Therapeutics: State of the Science
Birrer, M. J., Moore, K. N., Betella, I., & Bates, R. C. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz035 · Cited by 439
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Ovarian Cancer Immunotherapy and Personalized Medicine
Morand, S., Devanaboyina, M., Staats, H., Stanbery, L., & Nemunaitis, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126532 · Cited by 372
Technologies for circulating tumor cell separation from whole blood
Bankó, P., Lee, S. Y., Nagygyörgy, V., Zrínyi, M., Chae, C. H., Cho, D. H., & Telekes, A. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0735-4 · Cited by 358
Metadata
- Authors
- Assaraf, Y. G., Leamon, C. P., & Reddy, J. A.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 17
- Issue
- 4-6
- Pages
- 89-95
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W1973108158
- Cited by
- 398
- References
- 63
- FWCI
- 18.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.